Moleculin Biotech: chief science officer Donald H Picker received 250,000 shares

What happened

• Donald H Picker, chief science officer, received a grant of a stock option covering 250,000 shares on Oct 15, 2026. The filing lists the transaction as an award/grant (code A) and shows price N/A and total value N/A.

Key details

• Transaction date: Oct 15, 2026; price: N/A. Form 4 filed Oct 16, 2026.
• Shares owned after the transaction: the filing does not list shares owned after the transaction.
• Footnote F1: the option vests 50% on grant and 50% in 18 equal installments over 18 months.
• Footnote F2: issued in connection with the reporting person's employment with the company.

Why it may matter

• This filing reports a grant of options rather than a market purchase or sale; it does not show a sale or a cashless exercise.
• The filing does not show why the insider traded or why the company acted.